Geneos Wealth Management Inc. Novo Nordisk A S Transaction History

Geneos Wealth Management Inc.

$3.92 Billion
Q2 2025

A detailed history of Geneos Wealth Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 17,815 shares of NVO stock, worth $999,243. This represents 0.03% of its overall portfolio holdings.

Number of Shares

17,815

Previous 20,585 13.46%

Holding current value

$999,243

Previous $1.43 Million 14.0%

% of portfolio

0.03%

Previous 0.05%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 18, 2025	SELL	$58.08 - $81.05 $160,881 - $224,508	-2,770 Reduced 13.46%	17,815 $1.23 Million
Q1 2025 May 21, 2025	SELL	$69.3 - $90.95 $360,567 - $473,212	-5,203 Reduced 20.18%	20,585 $1.43 Million
Q1 2025 May 07, 2025	BUY	$69.3 - $90.95 $448,301 - $588,355	6,469 Added 33.49%	25,788 $1.79 Million
Q4 2024 Jan 21, 2025	SELL	$85.0 - $120.04 $211,055 - $298,059	-2,483 Reduced 11.39%	19,319 $1.66 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $680,365 - $830,929	5,714 Added 35.52%	21,802 $2.6 Million
Q2 2024 Jul 23, 2024	SELL	$122.71 - $146.91 $40,371 - $48,333	-329 Reduced 2.0%	16,088 $2.3 Million
Q1 2024 May 03, 2024	BUY	$102.11 - $135.92 $167,562 - $223,044	1,641 Added 11.11%	16,417 $2.11 Million
Q4 2023 Jan 26, 2024	BUY	$87.78 - $105.45 $65,835 - $79,087	750 Added 5.35%	14,776 $1.53 Million
Q3 2023 Oct 11, 2023	BUY	$90.94 - $199.54 $657,041 - $1.44 Million	7,225 Added 106.23%	14,026 $1.28 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $137,106 - $151,759	879 Added 14.84%	6,801 $1.1 Million
Q1 2023 Apr 25, 2023	BUY	$132.34 - $159.14 $214,258 - $257,647	1,619 Added 37.62%	5,922 $942,000
Q4 2022 Jan 30, 2023	BUY	$102.55 - $135.33 $283,038 - $373,510	2,760 Added 178.87%	4,303 $582,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $21,056 - $25,841	221 Added 16.72%	1,543 $153,000
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $3,406 - $4,019	-33 Reduced 2.44%	1,322 $147,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $4,096 - $4,951	44 Added 3.36%	1,355 $150,000
Q4 2021 Feb 09, 2022	BUY	$95.88 - $117.08 $39,119 - $47,768	408 Added 45.18%	1,311 $146,000
Q2 2021 Jul 08, 2021	SELL	$67.66 - $84.76 $9,810 - $12,290	-145 Reduced 13.84%	903 $76,000
Q4 2020 May 19, 2021	SELL	$63.89 - $73.8 $21,275 - $24,575	-333 Reduced 24.11%	1,048 $61,000
Q3 2020 Sep 07, 2021	BUY	$63.69 - $70.22 $6,369 - $7,022	100 Added 7.81%	1,381 $95,000
Q2 2020 Sep 07, 2021	BUY	$58.54 - $67.94 $5,854 - $6,794	100 Added 8.47%	1,281 $84,000
Q1 2020 Sep 07, 2021	SELL	$49.46 - $64.78 $47,728 - $62,512	-965 Reduced 44.97%	1,181 $66,000
Q4 2019 Sep 07, 2021	SELL	$49.86 - $58.26 $22,287 - $26,042	-447 Reduced 17.24%	2,146 $125,000
Q2 2019 Sep 07, 2021	SELL	$46.79 - $52.47 $28,074 - $31,482	-600 Reduced 18.79%	2,593 $132,000
Q1 2019 Sep 07, 2021	BUY	$46.36 - $52.63 $2,178 - $2,473	47 Added 1.49%	3,193 $167,000
Q4 2018 Sep 07, 2021	SELL	$41.54 - $47.25 $7,851 - $8,930	-189 Reduced 5.67%	3,146 $144,000
Q3 2018 Sep 07, 2021	SELL	$46.76 - $51.24 $84,635 - $92,744	-1,810 Reduced 35.18%	3,335 $157,000
Q2 2018 Sep 07, 2021	BUY	$44.29 - $50.42 $9,965 - $11,344	225 Added 4.57%	5,145 $237,000
Q1 2018 Sep 07, 2021	BUY	$48.49 - $58.14 $16,244 - $19,476	335 Added 7.31%	4,920 $242,000
Q4 2017 Sep 07, 2021	SELL	$47.53 - $53.73 $18,299 - $20,686	-385 Reduced 7.75%	4,585 $246,000
Q1 2017 Sep 07, 2021	BUY	N/A	360 Added 7.81%	4,970 $170,000
Q4 2016 Sep 07, 2021	BUY	N/A	641 Added 16.15%	4,610 $165,000
Q3 2016 Sep 07, 2021	BUY	N/A	89 Added 2.29%	3,969 $165,000
Q1 2016 Sep 07, 2021	BUY	N/A	3,880	3,880 $213,000

Others Institutions Holding NVO

# of Institutions

1,729

Shares Held

313M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $127B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Novo Nordisk A S Transaction History